title: Presentation of three different viral peptides, HTLV-1 Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule.
abstract: To determine whether similar or dissimilar molecular features of class I molecules are involved in the presentation of structurally distinct peptides, we have investigated the influence of different pockets of the HLA-A2.1 molecule on the presentation of three different viral peptides. HTLV-I Tax peptide 12-19, HCMV gB 619-628, and influenza M1 58-66 are minimal peptides that induce HLA-A2.1-restricted noncross-reactive CTL. A detailed analysis of the structural features of HLA-A2.1 that are involved in peptide presentation was undertaken using a panel of 11 HLA-A2 mutants with single amino acid substitutions within pockets present in the peptide binding site. Nine of the 11 mutants affected presentation of each of the three peptides, whereas the other two mutants had negative effects on presentation of only two of these viral peptides. These results indicate that common structural features in HLA-A2 determine the binding of different peptides, and help to provide a plausible explanation for how structurally diverse peptides bind to HLA-A2.
authors.affiliation: Molecular Immunology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH), Bethesda, MD 20892.
authors.forename: U
authors.initials: U
authors.lastname: Utz
authors.forename: S
authors.initials: S
authors.lastname: Koenig
authors.forename: J E
authors.initials: JE
authors.lastname: Coligan
authors.forename: W E
authors.initials: WE
authors.lastname: Biddison
mesh_terms: D000595:Amino Acid Sequence; D000938:Antigen-Presenting Cells / Q000276:immunology*; D000956:Antigens, Viral / Q000378:metabolism*; D001665:Binding Sites; D003602:Cytotoxicity, Immunologic; D016356:Gene Products, tax / Q000276:immunology; D015789:HLA-A2 Antigen / Q000737:chemistry / Q000378:metabolism*; D015368:Human T-lymphotropic virus 1 / Q000276:immunology*; D006801:Humans; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D010455:Peptides / Q000276:immunology*; D013329:Structure-Activity Relationship; D014759:Viral Envelope Proteins / Q000276:immunology; D014763:Viral Matrix Proteins / Q000276:immunology
chemical_list: D000956:Antigens, Viral; D016356:Gene Products, tax; D015789:HLA-A2 Antigen; C031540:M-protein, influenza virus; C488936:M1 protein, Influenza A virus; D010455:Peptides; D014759:Viral Envelope Proteins; D014763:Viral Matrix Proteins; C040495:glycoprotein B, Simplexvirus